The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma: is it cost effective?

GÜRER İ. E., Simsek T., Erdogan G., Atalay E., Zorlu C., Karaveli S., ...Daha Fazla

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, cilt.21, sa.2, ss.197-199, 2000 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 2
  • Basım Tarihi: 2000
  • Dergi Adı: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.197-199
  • Anahtar Kelimeler: endometrial, adenocarcinoma, prognostic, PCNA, p53, Ki-67, UEA 1, c-erb B2, estrogen, progesterone, MALIGNANT ENDOMETRIUM, PROGESTERONE-RECEPTOR, EXPRESSION, CARCINOMA, P53
  • Akdeniz Üniversitesi Adresli: Evet

Özet

This study investigated the relation between immunohistochemical prognostic factors and clinical stage and histopathological grade in endometrial adenocarcinoma.